180 related articles for article (PubMed ID: 30458864)
1. Trimethoprim-sulfamethoxazole induced circulatory shock in a human immunodeficiency virus uninfected patient: a case report and review.
Liu P; Ranches GP; Gold JA
BMC Pharmacol Toxicol; 2018 Nov; 19(1):76. PubMed ID: 30458864
[TBL] [Abstract][Full Text] [Related]
2. Atypical Severe Shock-like Reactions in Adolescents After Trimethoprim-Sulfamethoxazole Therapy.
Rathe JA; Poole N; Melvin A
J Pediatric Infect Dis Soc; 2021 Apr; 10(3):382-385. PubMed ID: 32955095
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of upfront graded administration of trimethoprim-sulfamethoxazole in systemic lupus erythematosus: A retrospective cohort study.
Suyama Y; Okada M; Rokutanda R; Min C; Sassé B; Kobayashi D; Takahashi O; Deshpande GA; Matsui K; Kawaguchi Y; Kishimoto M
Mod Rheumatol; 2016 Jul; 26(4):557-61. PubMed ID: 26587755
[TBL] [Abstract][Full Text] [Related]
4. Methemoglobinemia induced by trimethoprim-sulfamethoxazole in a patient with systemic lupus erythematosus.
Kawasumi H; Tanaka E; Hoshi D; Kawaguchi Y; Yamanaka H
Intern Med; 2013; 52(15):1741-3. PubMed ID: 23903510
[TBL] [Abstract][Full Text] [Related]
5. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.
Carr A; Penny R; Cooper DA
AIDS; 1993 Jan; 7(1):65-71. PubMed ID: 8442919
[TBL] [Abstract][Full Text] [Related]
7. Trimethoprim/Sulfamethoxazole-Induced Severe Lactic Acidosis: A Case Report and Review of the Literature.
Bulathsinghala M; Keefer K; Van de Louw A
Medicine (Baltimore); 2016 Apr; 95(17):e3478. PubMed ID: 27124045
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
Bell TL; Foster JN; Townsend ML
Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.
Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA
Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reactions to trimethoprim-sulfamethoxazole in systemic lupus erythematosus.
Izuka S; Yamashita H; Takahashi Y; Kaneko H
Lupus; 2021 Sep; 30(10):1679-1683. PubMed ID: 34304628
[TBL] [Abstract][Full Text] [Related]
11. Interstitial lung disease during trimethoprim/sulfamethoxazole administration.
Yuzurio S; Horita N; Shiota Y; Kanehiro A; Tanimoto M
Acta Med Okayama; 2010 Jun; 64(3):181-7. PubMed ID: 20596129
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia after initiation and rechallenge with trimethoprim-sulfamethoxazole in an older adult.
Huntsberry AM; Linnebur SA; Vejar M
Clin Interv Aging; 2015; 10():1091-6. PubMed ID: 26170649
[TBL] [Abstract][Full Text] [Related]
13. Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: A single-center retrospective observational cohort study.
Nakashima K; Aoshima M; Nakashita T; Hara M; Otsuki A; Noma S; Misawa M; Otsuka Y; Motojima S
J Microbiol Immunol Infect; 2018 Dec; 51(6):810-820. PubMed ID: 28779879
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous hypersensitivity reactions to trimethoprim-sulfamethoxazole and amoxicillin-clavulanate in a dog.
Jeong Y; Kim YH; Ahn JO; Chung JY
J Vet Sci; 2023 Nov; 24(6):e77. PubMed ID: 37904639
[TBL] [Abstract][Full Text] [Related]
15. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA
J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769
[TBL] [Abstract][Full Text] [Related]
16. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients.
Thomas M; Rupali P; Woodhouse A; Ellis-Pegler R
Scand J Infect Dis; 2009; 41(11-12):862-8. PubMed ID: 19922070
[TBL] [Abstract][Full Text] [Related]
17. The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. California Collaborative Treatment Group.
Bozzette SA; Forthal D; Sattler FR; Kemper C; Richman DD; Tilles JG; Leedom J; McCutchan JA
Am J Med; 1995 Feb; 98(2):177-82. PubMed ID: 7847434
[TBL] [Abstract][Full Text] [Related]
18. A case of hyperdynamic shock caused by trimethoprim-sulfamethoxazole in which no tumor necrosis factor or features of anaphylaxis were detected.
Nguyen BY; Landucci DL; Cunnion RE; Yarchoan R; Walker RE
Clin Infect Dis; 1993 Nov; 17(5):885-7. PubMed ID: 8286631
[TBL] [Abstract][Full Text] [Related]
19. [Sulfamethoxazole-trimethoprim-induced pneumonitis in a patient with hemophilia B who was infected with the human immunodeficiency virus].
Yamagishi T; Yoshida S; Fukutake K; Utsumi K; Ichinose Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):822-8. PubMed ID: 8810766
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-Sulfamethoxazole-Induced Drug Eruption With Eosinophilia and Systemic Symptoms (DRESS).
Antia C; Persad L; Alikhan A
J Drugs Dermatol; 2017 Oct; 16(10):1043-1046. PubMed ID: 29036260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
